Author:
Washington Christina R.,Moore Kathleen N.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Obstetrics and Gynecology
Reference15 articles.
1. Two decades beyond BRCA1/2: Homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy;Walsh;Gynecol Oncol,2015
2. DNA double-strand break repair pathway regulates PD-L1 expression in cancer cells;Sato;Nat Commun,2017
3. An open-label, multicohort, phase I/II study of nivolumab in patients with virus-associated tumors (CheckMate 358): efficacy and safety in recurrent or metastatic (R/M) cervical, vaginal, and vulvar cancers;Hollebecque;J Clin Oncol,2017
4. Olaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation;Kaufman;J Clin Oncol,2015
5. A phase III study comparing single-agent olaparib or the combination of cediranib and olaparib to standard platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer;Liu;J Clin Oncol,2020
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献